BEIJING – With the world’s largest cancer epidemic, China has been one of the most rapidly expanding markets for oncologic drugs for years. Now, an alternative approach is growing about twice as fast: traditional Chinese medicines.
Sales of traditional cancer treatments, often containing ingredients as unlikely as toad skin and turtle shell, surged 35 percent to almost 17 billion yuan ($2.7 billion) last year, market researcher Sinohealth Intelligence estimates.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.
We humbly apologize for the inconvenience.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.